Journal Policy

Open Access Policy

All research articles published in KSV Journal of Pharmacy and Health Science are fully Open Access: immediately freely available to read, download and share. An Open Access Publication is one that meets the following two conditions:

  1. The author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
  2. A complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution & scholarly society that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving.

Notes:

  1. Open Access is a property of individual works, not necessarily journals or publishers.
  2. Community standards, rather than copyright law, will continue to provide the mechanism for enforcement of proper attribution and responsible use of the published work, as they do now.

* Allows users to copy, distribute and transmit an article, adapt the article as long as the author is attributed, and the article is not used for commercial purposes.

KSV Journal of Pharmacy and Health Science 

Kadi Sarva Vishwavidyalaya Journal of Pharmacy and Health Science IS AN OFFICIAL PUBLICATION OF K. B. Institute of Pharmaceutical Education and Research, will not consider any studies involving humans or animals without the appropriate approval. If no formal ethics committee is available, the authors should indicate whether the procedures were compliant with the Helsinki Declaration as revised in 2008. Informed consent should be obtained, unless waived by the Institutional Review Board, from patients who participated in clinical investigations. Human subjects should not be identifiable, such that patients' names, initials, hospital numbers, dates of birth, or other protected healthcare information should not be disclosed. If experiments involve animals, the research should be based on national or institutional guidelines for animal care and use. Original articles submitted to KSV Journal of Pharmacy and Health Sciences e-JOURNAL that address any investigation involving humans and animals should include a description about whether the study was conducted under an approval by the Institutional Review Board (with or without patient informed consent) and animal care committee, respectively, of the institution where the study was conducted.

Policy Statement – Conflict of Interest

All Authors publishing in KSV Journal of Pharmacy and Health Sciences e-JOURNAL must declare all financial disclosures and conflicts of interest in the article file of manuscripts submitted for publication.

For more information on Conflict of Interest, see the guidelines from the ICMJE.

Policy Statement – Informed Consent

All human studies submitted for publication in KSV Journal of Pharmacy and Health Sciences e-JOURNAL require informed consent and ethics committee approval. If waiver of consent was granted by the ethics committee in the case of retrospective studies not impacting on patient confidentiality or patient rights, this must be clearly stated in the cover letter and manuscript.

Plagiarism Policy

The KSV Journal of Pharmacy and Health Sciences e-JOURNAL is dedicated to publishing only original material. The journal staff has a policy of screening for plagiarism. All articles in this publication are original: the content (either in full or in part) in each article has not been knowingly republished without specific citation to the original release.

KSV Journal of Pharmacy and Health Sciences e-JOURNAL uses authenticate software to detect submissions that overlap with published and submitted manuscripts. Editors can see our Similarity Check page for more information on how to interpret these reports.

Manuscripts that are found to have been plagiarized from a manuscript by other authors, whether published or unpublished, will be rejected and the authors may incur sanctions. Any published articles may need to be corrected or retracted.

If any manuscript is found to be plagiarized, immediate action will be taken, which will include and not limited to the following:

  1. Retraction of paper in question, from online system, review, and from all other processing.
  2. Black listing of concerned author(s) in question.
  3. Rejection of all other manuscripts submitted by the author(s) in question.
  4. Reporting of the issue to the concerned authorities, including the authors' institution.

Note: KSV Journal of Pharmacy and Health Sciences E-JOURNAL encourages the submission of original articles by authors. Acts of plagiarism will not be condoled by the journals. Submitted work if discovered to be plagiarized will be withdrawn from the journal's website and legal action may be taken against such author if deemed necessary.

Waiver Policy for Article processing charges (APC): At present no processing charges.

KSV Journal of Pharmacy and Health Sciences e-JOURNAL is an Open Access journal although there is no Article submission charges, a fee is payable by the author or research funder to cover the costs associated with publication.

Publishing an article in this Journal requires Article Processing Charges that will be billed to the submitting author following the acceptance of an article for publication.

Data Sharing Policy

KSV Journal of Pharmacy and Health Sciences e-JOURNAL uses the Basic Data Sharing Policy. Authors are encouraged to share or make open the data supporting the results or analyses presented in their paper where this does not violate the protection of human subjects or other valid privacy or security concerns.

Authors are further encouraged to cite any data sets referenced in the article and provide a Data Availability Statement.

Please note: As you are submitting your manuscript to KSV Journal of Pharmacy and Health Sciences e-JOURNAL where submissions are double-blind peer reviewed, the main text file should not include any information that might identify the authors (i.e. Author Name, Address, Conflict of Interest and fund related information). As a data availability statement could reveal your identity, we recommend that you remove this from the anonymized version of the manuscript.

There are several benefits to sharing data:

  • Sharing data publicly improves the robustness of the research process, supporting validation, research transparency, reproducibility and replicability of results. This can in turn, advance discovery and knowledge.
  • Sharing data can lead to re-use and discovery, with greater opportunities for carrying out meta-analyses and the extraction of new knowledge.
  • Depositing data in a repository that mints a permanent identifier such as a DOI, allows authors and others to cite the data set, allowing researchers to get appropriate credit for their work.
  • Data deposition supports the preservation of data long term.
  • Wider public availability of research data supports the translation of research into practice.

Data Policies

KSV Journal of Pharmacy and Health Sciences E-JOURNAL offers the following standardized data sharing policies across our journals:

  • Basic – Journal encourages authors to share and make data open where this does not violate protection of human subjects or other valid subject privacy concerns. Authors are further encouraged to cite data and provide a data availability statement.
  • Share upon reasonable request– Authors agree to make their data available upon reasonable request. It’s up to the author to determine whether a request is reasonable.
  • Publicly available– Authors make their data freely available to the public, under a license of their choice.
  • Open data– Authors must make their data freely available to the public, under a license allowing re-use by any third party for any lawful purpose. Data shall be findable and fully accessible.
  • Open and fully FAIR (Findable, accessible, interoperable and re-usable)– Authors must make their data freely available to the public, under a license allowing re-use by any third party for any lawful purpose. Additionally, data shall meet with FAIR standards as established in the relevant subject area.

The diagram above shows the typical workflow of an author submitting a paper to a journal with the basic data sharing policy.

Data Citation

There are numerous referencing styles available and each journal’s Instructions for Authors will include information on the recommended style – always check there before referencing data in your article.

Generally, all reference styles will include: a persistent identifier (e.g. DOI) where this is available, the location of the data and the name(s) of the individual(s) responsible for the creation of the data, and the tag “[dataset]”.

Appeals

Journals should consider establishing and publishing a mechanism for authors to appeal editorial decisions, to facilitate genuine appeals, and to discourage repeated or unfounded appeals.

  • Editors should allow appeals to override earlier decisions following appropriate reconsideration of the editorial process and decision making (for example, additional factual input by the authors, revisions, extra material in the manuscript, or appeals about conflicts of interest and concerns about biased peer review).
  • Editors should mediate all exchanges between authors and peer reviewers during the peer-review process. Editors may seek comments from additional peer reviewers to help them make their final decision. Journals state in their guidelines that the editor’s decision following an appeal is final.

Authors and contributors

Authorship gives recognition and credit for work done, accountability for reported research, confers moral and legal rights (copyright) and plays an important role in shaping academic careers. However, authorship issues remain a common concern faced by editors. COPE’s discussion document on authorship explores the issues in detail and provides practical advice.

There is no universal definition of authorship, and practices vary by discipline and communities especially when individuals collaborate across subject areas. Different disciplines adopt their own criteria, for example, the ICMJE (International Committee of Medical Journal Editors) guidelines are well-known in the biomedical fields, the APA (American Psychological Association) guidelines are used in Psychology, the EuChemS (European Chemical Society) guidelines are adopted in Chemistry, whereas in the arts, humanities and social sciences, publications by single authors are more common. However, the minimum recognized requirements for authorship are making a substantial contribution to the research and being accountable for the work undertaken.

Many journals require authors to confirm, on submission, that they and their co-authors meet the requirements for authorship and typically provide an ORCID (Open Researcher Contributor ID). An ORCID provides a persistent digital identifier to distinguish individuals from others with similar names and links individuals to their research outputs.

Journals should notify all authors that they have received a submission and confirm that emails are not invalid. To increase transparency, it is helpful for journals to publish “author contribution statements” that explain how each author contributed to a piece of work. This approach has been recently extended by the CRediT “Contributor Roles Taxonomy” an open standard of 14 item terms that allows for a standardized description of each author’s individual contribution to an manuscript.

An individual who does not meet authorship criteria for a specific piece of work but has contributed in some capacity should be acknowledged, with their approval. Minors who have been involved in a piece of research (for example, children using technology) are typically acknowledged as they cannot be fully accountable for all aspects of the research.

Artificial Intelligence Generated Content

Artificial Intelligence Generated Content (AIGC) tools—such as ChatGPT and others based on large language models (LLMs)—cannot be considered capable of initiating an original piece of research without direction by human authors. They also cannot be accountable for a published work or for research design, which is a generally held requirement of authorship nor do they have legal standing or the ability to hold or assign copyright. If an author has used this kind of tool to develop any portion of a manuscript, its use must be described, transparently and in detail, in the Methods or Acknowledgements section. The author is fully responsible for the accuracy of any information provided by the tool and for correctly referencing any supporting work on which that information depends. Tools that are used to improve spelling, grammar, and general editing are not included in the scope of these guidelines. 

Deceased authors

If a manuscript is submitted with a deceased author listed, or an author passes away while the manuscript is being peer reviewed, then a footnote or similar should be added to the published article to indicate this. Often journals use a dagger symbol (†) with a footnote explaining the situation. A co-author should vouch for the contribution made by the deceased author and their potential conflicts of interest. If the deceased author was a corresponding author then another co-author should be nominated. Note that copyright is considered personal property under the law. If the author had not yet signed a copyright transfer agreement or license, or granted a co-author the right to do so on his/her behalf in writing, permission would need to be obtained from the author’s inheritor.

Editor and journal staff as author:

Editors or board members should not be involved in editorial decisions about their own scholarly work. Editors and editorial team members are excluded from publication decisions when they are authors or have contributed to a manuscript.

Commercial consideration and editorial independence

It is impossible to completely insulate editorial decisions from issues that may influence them, such as commercial considerations. Even so, editors, journal owners, and publishers follows processes that minimize the risk of editorial decisions being influenced by commercial, personal, or political factors. Following point are considered.

  • Editors should be free to judge all submissions on their scholarly merit and on their potential importance to the community that the journal serves.
  • Editorial decisions about individual papers should remain separate from the sale of advertising.
  • Journal that publish special issues, conference abstract, supplements, or similar material that is funded or sponsored or under agreement of publisher of this journal by third-party organizations.
  • Journal does not permit funding organizations to make decisions beyond which publications they choose to fund. Decisions about the selection and editing of contents to be published should be made by the editor (or co-editors) of the funded publication.
  • A journal editor may elect to use “guest” or external editors to support the publishing of supplements, special issues, or similar publications.
  • Editors’ decisions about whether to publish individual manuscripts submitted to their journal does/should not be influenced by pressure Ideally, the principles of editorial independence is set out.

Further discussion of editorial independence is presented by the Council of Science Editors and in COPE’s Core Practices.

Conflict of Interest

The International Committee of Medical Journal Editors has created a uniform disclosure form for conflicts of interest.

Correction, reaction, retraction, withdrawal and expression of concern:

Correction

Journal encourages readers and authors to notify them if they find error. Once notified, journal will work with author to correct significant errors. Following are few illustrative/ examples

  • Important content is incorrect
  • Error affect interpretation of data or information presented in article
  • Improper acknowledgement
  • article author details are missing or authenticate

journal welcomed feedback on all error in order to improve. Please accept limitation that no all error requires correction after publication. Minor typesetting or typological error that do not affect the meaning and interpretation of an article are not corrected after publication. To the best journal try to publish errata or addendum.

When any error is identified: depend on seriousness of the error, editor is free to take action rom retraction to correction depends on which stage of publication error has been notified.

Retraction Policy

Journals is committed in maintaining the integrity of the scholarly record, therefore on occasion, it may be necessary to retract articles. COPE has published guidelines for retracting articles which suggest that journal should consider publishing retractions for articles when:

  • Finding are unreal.
  • Evident and constitute major plagiarism.
  • Case of redundant publication: the finding has been published elsewhere without proper attribution of the previous source or disclosure to the editors, permission to republished or justification
  • Data without authorisation for use
  • Reports unethical reports
  • Copyright has been infringed or there is some other serious legal issue
  • Publication on the basis of a compromised or manipulated peer review process.

In case of retraction:

The title of retraction should include the word “Retraction” and information to identify the article that refers to. It should be published on a numbered page and should be listed in journal’s table of content, it should cite the article and link publication wherever/whenever possible. It should enable readers to identify and understand which article has been retracted for reason.

Retraction process:

In orders to handle that retraction are handled according to fair practice and in accordance to COPE guideline. Journal adopts and follow following process:

  1. An article requiring potential retraction is brought to the attention of the journal editor.
  2. The journal editor should follow the step-by-step guidelines according to the COPE flowcharts (including evaluating a response from the author of the article in question).
  3. Before any action is taken, the editor's findings should be sent to editorial board, expert advisory and publisher for review. The purpose of this step is to ensure a consistent approach in accordance with best practice.
  4. The final decision as to whether to retract is then communicated to the author and, if necessary, any other relevant bodies, such as the author's institution on occasion.
  5. The retraction statement is then posted online and published in the next available issue of the journal (see below for more details of this step).

When it is decided to retract:

Follow the process as mentioned above and add water mark retracted in soft copy version.

Withdrawal

There may be a circumstances under which an article may be withdrawn following publication. Editorial ask for withdrawal. Following can be circumstance under which it can be withdrawn:

In case of accepted and published article:

  • An accepted article is the uncorrected, unedited and non-typeset version of an article published.
  • Article is retracted because of reasons.
  • Accidently submitted multiple time.
  • Infringes ethical code

Hazardous material and risk and Biosecurity

Authors are responsible to identify any unusual inherent hazards or risks in a manuscript, include appropriate warnings, and refer to relevant safety precautions. This could be products, chemicals, operations, or technologies posing a threat to public health and safety, the environment, plants, animals, or equipment. Journal advice author to refer relevant guideline about biosecurity, biodiversity, environment protection act and concern to articles.

Copyright and Intellectual Property

It is a legal requirement for an author to sign a copyright agreement before publication.

Copyright Transfer Agreement (CTA)

Under this form of agreement, the author retains broad re-use rights in their article, but transfers copyright to the journal or publisher. Signing a CTA ensures maximum protection against copyright infringement with the publisher acting on behalf of the author.

The KSV Journal of Pharmacy and Health Sciences e-JOURNAL require a formal written transfer of copyright from the author(s) for each article published (Copyright Form). We therefore ask Author’s to complete and return this form, retaining a copy for records. Author’s cooperation is essential and appreciated. Any delay will result in a delay in publication.

Online Open Access Statement

The KSV KSV Journal of Pharmacy and Health Sciences e-JOURNAL use article open access policy by providing them to be made available in order to meet the terms of open access publication and ensure the widest possible dissemination.

All articles published open access will be immediately and permanently free for everyone to read, download, copy and distribute.